This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Glycotope Gmbh. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Rainer Stahn: Innovator in Myeloid Leukaemia Cell Culturing
Introduction
Rainer Stahn is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of cell culturing, particularly in relation to human myeloid leukaemia cells. His innovative methods have the potential to enhance research and treatment options in oncology.
Latest Patents
Rainer Stahn holds a patent for "Methods for culturing human myeloid leukaemia cells and cells derived therefrom." This invention pertains to a method for culturing a suspension of immortalized human blood cells, specifically those of myeloid leukaemia origin. The method provides high productivity, cell viability, growth rate, and batch-to-batch consistency, and it can be scaled up without altering these parameters. He has 1 patent to his name.
Career Highlights
Rainer Stahn is associated with Glycotope GmbH, a company that focuses on biopharmaceutical development. His work at Glycotope has allowed him to apply his innovative methods in a practical setting, contributing to advancements in cancer research.
Collaborations
Rainer collaborates with Steffen Kreye, a fellow professional in the field. Their partnership enhances the research and development efforts at Glycotope GmbH.
Conclusion
Rainer Stahn's contributions to the field of cell culturing, particularly in myeloid leukaemia, demonstrate his commitment to innovation in medical research. His work has the potential to significantly impact the treatment of leukaemia and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile